FRCPath2Macro_Feb 2012 Final
Transcript of FRCPath2Macro_Feb 2012 Final
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
1/43
The FRCPath SurgicalPathology Module
macroscopic specimens
Helen Baker
Consultant Histopathologist
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
2/43
CASE 1. BreastKey - Wide local excision for mammography screening detected breastlump.Specimen sliced from medial to lateral aspects.Yellow paint - superiorBlue paint - anteriorRed paint - inferior
1) Indicate on the diagram the blocks you would take from thisspecimen.2) What other information would you record before and during specimendissection?3) How would you modify your specimen dissection for a wide local
excision if a tumour mass was not visible and for DCIS?4) How would you deal with:
a) cavity shaves ?b) sentinel lymph nodes ?
5) What additional blocks would you take in a mastectomy case and givetheir rationale?
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
3/43
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
4/43
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
5/43
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
6/43
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
7/43
CASE 1. Breast
1) Indicate on the diagram the blocks you would takefrom this specimen.
Tumour and involved / nearest margins. Adjacent fibrotictissue. Anterior and posterior to the tumour/DCIS inlarger WLEs to assess extent of DCIS, which canbe more than measured radiologically,macroscopically. Spreads in this plane, along ducts.Any unusual areas and associated margins.
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
8/43
Case 1
2) What other information would you record before and duringspecimen dissection?
Accompanying X- Ray present or absent. If lesion is
visible in WLE, describe the lesion. Presence of guide-wireand its relation to the lesion.
Weight of specimen, measurement of specimen in threedimensions. Measurement of tumour in three dimensionsand distance to margins. Record abnormal lesions and
relations to margins. Block code essential, +/- diagram.
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
9/43
Case 1
3) What additional blocks would you take in a mastectomycase and give their rationale
Tumour to give dimensions and relevant margins
Nipple -areolar complex Paget'sAdjacent / ant and post to tumour for accurate sizing
Any abnormal area and margins
Random quadrantic blocks background breast / occultextensive disease
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
10/43
Case 14) How would you deal with:a) cavity shaves ?
b) sentinel lymph nodes ?
Cavity shave measure, paint , orientate with different colours if
orientated by surgeon. Serially slice, all embed.Sentinel node radioactive time lapse before dissection.
Measure , record if blue, record size of entire tissue and nodesize, serially slice node at 2mm intervals , CAM5.2 or equivalent
marker, levels. Report H& E and immunos in conjunction.
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
11/43
Common Errors by Candidates
No mention of X-ray
cavity shave limited to block it all
mastectomy: no mention of backgroundbreast; no mention of axillary tail or lymphnodes
cruciate means like a cross
no block code
gigantic blocks; indiscriminate blocks
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
12/43
CASE 2. Prostate
1) Indicate on the photograph the blocks you would take from thisspecimen
2) What other information would you record prior to and duringspecimen dissection ?
3) How would you deal with accompanying lymphadenectomyspecimens ?
4) What characteristics of the tumour would you reporthistologically ?
5) What immunohistochemical stains may help you in reportingprostatectomy specimens ?
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
13/43
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
14/43
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
15/43
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
16/43
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
17/43
CASE 2. Prostate
1) Indicate on the photograph the blocks you would take from thisspecimen
2) What other information would you record prior to and duringspecimen dissection ?
3) How would you deal with accompanying lymphadenectomyspecimens ?
4) What characteristics of the tumour would you reporthistologically ?
5) What immunohistochemical stains may help you in reportingprostatectomy specimens ?
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
18/43
Case 2 - Answers
Vas margins, apex and base margins, seminal vesicles, slice at 3-5mm intervals, whole mount or extensive sampling of CRM
Weight , size, visible tumour location and size, number of slices,photographs if facilities available. Block code.
Identify and separate nodes. Rest of fat to be processed
Type, differentiation, grade, perineural and vascular invasion,location ant, post, central, lateral, multifocal, zones, % glandinvolvement / volume of tumour, breach of margins, extension intofat, seminal vesicles, involve of apical and base blocks, otherorgans
PSA, PSAP confirming prostatic origin. 34BetaE12 or CK5/6 distinguishing invasive from in situ disease. AMACR increasedexpression in cancer and in situ disease. Combined immunos.
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
19/43
Common Errors by Candidates
block code
gigantic blocks; indiscriminate blocks
other information: no description of visibletumour
not processing fat for lymph nodes
lots of things left out of Minimum Data Set:why block it if youre not going to write aboutit?
immunos: not mentioning prostatic markers
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
20/43
Case 3
Soft Tissue -
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
21/43
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
22/43
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
23/43
Case 3 Soft Tissue
What information would you include in your report ?
Macroscopy
Specimen weighed and measured in three dimensions
Plane of section in which tumour located should be recorded
Measurements of tumour to nearest margins, including anteriorand posterior
Dimensions of tumour
Tumour characteristics cystic areas, solid areas,haemorrhage, necrosis assess percentage, different colours,consistencies.
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
24/43
Case 3 Soft Tissue
Blocks 1 per cm, at leastBlocks from each different area of consistencyBlocks to include nearest marginsSpecimen less than 50mm m.d. all embedHigh grade lesions diagnosed on biopsy may need fewerblocksDedifferentiated liposarcoma, esp. undifferentiated
pleomorphic sarcomas or myxofibrosarcomas innocuousfatty tissue at edge of lesion sampled thoroughly for welldifferentiated liposarcoma areas
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
25/43
Case 3 Soft Tissue
Minimal info in report:
1 - Size of tumour
2 - Histological type
3 - Grade, FNCLCC;
4 - Tissue planes involved
5 - Tumour invasive edge; pushing/infiltrative
6 - Margins: Distance to the nearest margin
Tissue forming margin e.g. muscle, fascia
7 - Vascular invasion
8 - Genetic findings
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
26/43
Case 3 Soft Tissue
What advice would you give to clinicians and thelaboratory after removal of resection specimens and corebiopsies ?
Clinicians Biopsies - Fix in formalin promptly
Some tissue can be separated and frozen in liquid nitrogen -genetic studies.
Encourage clinicians to send resections promptly - fresh sampled for genetic studies, better histology
Easier to orientate before fixation
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
27/43
Case 3 Soft Tissue
Surgeons should be encouraged to orientate specimens in astandard fashion agreed between both the surgeon and thepathologist, and provide diagrams in particularly complexcases.
Laboratory
Promptly inform pathologist of arrival of specimen, so freshtissue can be taken for cytogenetics and the tissue can bepainted and sliced promptly for optimum tissue fixation.
Shallow H&E sections initially with biopsies to preserve tissuewhich may be required for immunohistochemistry and ancillarytests.
Fatty tissue may require extra fixation before processing.
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
28/43
Case 3 Soft Tissue
What system of grading is used for sarcomas and whathistological parameters are measured ?
French Federation of Cancer Centers System of Grading
Tumour differentiation
Score 1 Sarcoma histologically very similar to normal adultmesenchymal tissue
2 Sarcoma of defined histological subtype (e.g.myxofibrosarcoma)
3 Sarcoma of uncertain type, embryonal and undifferentiatedsarcomas
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
29/43
Case 3 Soft Tissue
Mitosis countScore 1 09 10 HPF2 1019 10 HPF3 >20 10 HPF
Microscopic tumour necrosisScore 0 - No necrosis1 < 50% tumour necrosis2 > 50% tumour necrosis
Histological gradeGrade 1 Total score 2 or 3Grade 2 Total score 4 or 5Grade 3 Total score 6, 7 or 8
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
30/43
Common Errors
no vascular invasion
no tissue planes involved
no margins: pushing/infiltrative no type of differentiation
no information about standard gradingsystem
funny sized blocks
no sampling of different areas
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
31/43
Case 4 Colon
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
32/43
Briefly note the macroscopic and microscopic featuresyou would record
Macroscopy
Type of resection
Mucosal abnormalities and distribution of disease process proximal, distal, continuous, patchy
Full thickness of wall involved ?
Fat wrapping
Serosal abnormalities
Adhesions/ attached organs
Case 4 Colon
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
33/43
Macroscopy
Strictures
Tumours
Polyps/ raised areas
Perforations Prominent nodes
Tissue sampling
Proximal and distal resection margins Mapped samples of bowel at regular (at least10cm) intervals
Note if abnormal or normal mucosa
Interfaces between diseased and non diseased areas
Case 4 Colon
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
34/43
Tissue sampling
Polyps
Raised areas and sampled flat mucosa around them
Strictures
Tumours
Serosal abnormalities
Attached organs
Sample lymph nodes
Case 4 Colon
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
35/43
Microscopy Active inflammation
LP cellularity
Crypt irregularities
Mucin depletion
Pattern of inflammation mucosal, transmural ulceration deep fissuring, shallow, perforation
patchy, continuous
granulomata
Fibrosis
Dysplasia/ tumours inc staging. DALMs
Margin involvement/ viability
Supervening infections i.e. CMV
Nodes reactive, granulomata
Case 4 Colon
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
36/43
What disease entities would you be considering with thismacroscopic picture and what clinical information wouldbe optimal before reporting the specimen ?
Idiopathic inflammatory bowel disease Crohn's disease
Ulcerative colitis
Indeterminate colitis
Pseudomembranous / infective
Ischaemia
Demographics
Imaging
Case 4 Colon
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
37/43
What disease entities would you be considering with thismacroscopic picture and what clinical information wouldbe optimal before reporting the specimen ?
Involved bowel segments Fistulae/ cutaneous manifestations
Other associated diseases
Topical treatment
Arteriopath ?
Recent antibiotics
Foreign travel
Case 4 Colon
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
38/43
In the presence of dysplasia, what other histologicalinformation should be given ?
Grade Low or high
Sporadic adenoma type flat, tva, va, serrated. DALM need tissue from around to distinguish
Extent of dysplasia
Associated invasive disease
Margins
Case 4 Colon
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
39/43
Common Errors
no mention of fat wrapping or of skiplesions
Topography no lymph node or appendix block
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
40/43
Macro Score Summary
15 candidates submitted their macros
13 Pass mark
1 B/L 1 Fail
Overall you did very well!
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
41/43
Summary
Sections that were well answered: Breast , Prostate + Colon generally answered well.
Sections candidates struggled on:
Soft Tissue case was less well done.
Candidates only answering about Microscopy findings on report + notmentioning Macroscopy.
Summary of common mistakes:
Not using X-rays in DCIS.
Not mentioning vascular invasion. Not mentioning use of immuno in sentinel node protocol.
Lots of people forgot to say they would document color code andblock key on breast + prostate cases.
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
42/43
Final advice for candidates
Read the question in full and answereach point.
Explanatory notes next to blocks aboutgeneral approach or significance of
taking a specific block helps examinergain an understanding of yourapproach.
-
8/2/2019 FRCPath2Macro_Feb 2012 Final
43/43
The End